Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 167

1.

Angiotensin-converting enzyme inhibitors and Alzheimer's disease progression in older adults: results from the Réseau sur la Maladie d'Alzheimer Français cohort.

Soto ME, van Kan GA, Nourhashemi F, Gillette-Guyonnet S, Cesari M, Cantet C, Rolland Y, Vellas B.

J Am Geriatr Soc. 2013 Sep;61(9):1482-8. doi: 10.1111/jgs.12415. Epub 2013 Sep 3.

PMID:
24000874
2.

Relation between use of angiotensin-converting enzyme inhibitors and muscle strength and physical function in older women: an observational study.

Onder G, Penninx BW, Balkrishnan R, Fried LP, Chaves PH, Williamson J, Carter C, Di Bari M, Guralnik JM, Pahor M.

Lancet. 2002 Mar 16;359(9310):926-30.

PMID:
11918911
3.

Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health Study.

Sink KM, Leng X, Williamson J, Kritchevsky SB, Yaffe K, Kuller L, Yasar S, Atkinson H, Robbins M, Psaty B, Goff DC Jr.

Arch Intern Med. 2009 Jul 13;169(13):1195-202. doi: 10.1001/archinternmed.2009.175.

4.

Weight loss and rapid cognitive decline in community-dwelling patients with Alzheimer's disease.

Soto ME, Secher M, Gillette-Guyonnet S, Abellan van Kan G, Andrieu S, Nourhashemi F, Rolland Y, Vellas B.

J Alzheimers Dis. 2012;28(3):647-54. doi: 10.3233/JAD-2011-110713.

PMID:
22045479
5.

Effects of centrally acting angiotensin converting enzyme inhibitors on functional decline in patients with Alzheimer's disease.

O'Caoimh R, Healy L, Gao Y, Svendrovski A, Kerins DM, Eustace J, Kehoe PG, Guyatt G, Molloy DW.

J Alzheimers Dis. 2014;40(3):595-603. doi: 10.3233/JAD-131694.

PMID:
24496072
6.

Angiotensin converting enzyme serum activities: Relationship with Alzheimer's disease.

Zhuang S, Wang X, Wang HF, Li J, Wang HY, Zhang HZ, Xing CM.

Brain Res. 2016 Nov 1;1650:196-202. doi: 10.1016/j.brainres.2016.09.002. Epub 2016 Sep 5.

PMID:
27608957
7.

Cardiovascular disease risk factors and progression of Alzheimer's disease.

Abellan van Kan G, Rolland Y, Nourhashémi F, Coley N, Andrieu S, Vellas B.

Dement Geriatr Cogn Disord. 2009;27(3):240-6. doi: 10.1159/000203365. Epub 2009 Feb 21.

PMID:
19246908
8.

Angiotensin-converting enzyme inhibitors and incidence of mild cognitive impairment. The Italian Longitudinal Study on Aging.

Solfrizzi V, Scafato E, Frisardi V, Seripa D, Logroscino G, Kehoe PG, Imbimbo BP, Baldereschi M, Crepaldi G, Di Carlo A, Galluzzo L, Gandin C, Inzitari D, Maggi S, Pilotto A, Panza F; Italian Longitudinal Study on Aging Working Group.

Age (Dordr). 2013 Apr;35(2):441-53. doi: 10.1007/s11357-011-9360-z. Epub 2011 Dec 28.

9.

Impact of renin-angiotensin system-targeting antihypertensive drugs on treatment of Alzheimer's disease: a meta-analysis.

Ye R, Hu Y, Yao A, Yang Y, Shi Y, Jiang Y, Zhang J.

Int J Clin Pract. 2015 Jun;69(6):674-81. doi: 10.1111/ijcp.12626. Epub 2015 Feb 27.

PMID:
25721930
10.

Angiotensin converting enzyme (ACE) inhibitors modulate the rate of progression of amnestic mild cognitive impairment.

Rozzini L, Chilovi BV, Bertoletti E, Conti M, Del Rio I, Trabucchi M, Padovani A.

Int J Geriatr Psychiatry. 2006 Jun;21(6):550-5.

PMID:
16642542
11.

Antihypertensive Treatment is associated with MRI-Derived Markers of Neurodegeneration and Impaired Cognition: A Propensity-Weighted Cohort Study.

Edwards JD, Ramirez J, Callahan BL, Tobe SW, Oh P, Berezuk C, Lanctôt K, Swardfager W, Nestor S, Kiss A, Strother S, Black SE; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2017;59(3):1113-1122. doi: 10.3233/JAD-170238.

PMID:
28731439
12.

Modulation of Renin-Angiotensin System May Slow Conversion from Mild Cognitive Impairment to Alzheimer's Disease.

Wharton W, Goldstein FC, Zhao L, Steenland K, Levey AI, Hajjar I.

J Am Geriatr Soc. 2015 Sep;63(9):1749-56. doi: 10.1111/jgs.13627.

13.

[The benefit of angiotensin converting enzyme inhibitor for geriatric syndrome in the elderly].

Ebihara T, Ohrui T, Ebihara S, Tsuji I, Sasaki H, Arai H.

Nihon Ronen Igakkai Zasshi. 2007 Jul;44(4):448-51. Japanese.

14.

Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease.

Sanz C, Andrieu S, Sinclair A, Hanaire H, Vellas B; REAL.FR Study Group.

Neurology. 2009 Oct 27;73(17):1359-66. doi: 10.1212/WNL.0b013e3181bd80e9.

PMID:
19858457
15.

Angiotensin converting enzyme inhibitors and cognitive and functional decline in patients with Alzheimer's disease: an observational study.

Hajjar IM, Keown M, Lewis P, Almor A.

Am J Alzheimers Dis Other Demen. 2008 Feb-Mar;23(1):77-83. doi: 10.1177/1533317507309803.

PMID:
18276960
16.

Effects of low blood pressure in cognitively impaired elderly patients treated with antihypertensive drugs.

Mossello E, Pieraccioli M, Nesti N, Bulgaresi M, Lorenzi C, Caleri V, Tonon E, Cavallini MC, Baroncini C, Di Bari M, Baldasseroni S, Cantini C, Biagini CA, Marchionni N, Ungar A.

JAMA Intern Med. 2015 Apr;175(4):578-85. doi: 10.1001/jamainternmed.2014.8164.

PMID:
25730775
17.

Persistent use of analgesic medications in mild-to-moderate Alzheimer's disease.

Gallini A, Gardette V, Vellas B, Lapeyre-Mestre M, Andrieu S, Brefel-Courbon C; REAL.FR/DSA group.

Drugs Aging. 2013 Jun;30(6):439-45. doi: 10.1007/s40266-013-0070-3.

18.

Long-term progression of Alzheimer's disease in patients under antidementia drugs.

Gillette-Guyonnet S, Andrieu S, Nourhashemi F, Gardette V, Coley N, Cantet C, Gauthier S, Ousset PJ, Vellas B; REAL.FR study group.

Alzheimers Dement. 2011 Nov;7(6):579-92. doi: 10.1016/j.jalz.2011.02.009.

PMID:
22055975
19.

Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies.

Anderson C, Teo K, Gao P, Arima H, Dans A, Unger T, Commerford P, Dyal L, Schumacher H, Pogue J, Paolasso E, Holwerda N, Chazova I, Binbrek A, Young J, Yusuf S; ONTARGET and TRANSCEND Investigators.

Lancet Neurol. 2011 Jan;10(1):43-53. doi: 10.1016/S1474-4422(10)70250-7. Epub 2010 Oct 25.

PMID:
20980201
20.

Supplemental Content

Support Center